Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

2012159 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov Identifier: NCT01301430.

Good health and well-being

Published in: BMC Cancer

Volume 12, Issue 1, pp. 99-99

Field-Weighted Citation Impact: 11.98